ロード中...
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic stem cell transplantation (HCT) is currently the standard of care for most patients with high-risk acute leukemias and some other hematologic malignancies. Although HCT can be curative, many patients who undergo allogeneic HCT will later relapse. There is, therefore, a criti...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3590108/ https://ncbi.nlm.nih.gov/pubmed/22992235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ehm.12.28 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|